Yayınlar & Eserler

Yayın Ağı
Makaleler 39
Tümü (39)
SCI-E, SSCI, AHCI (30)
SCI-E, SSCI, AHCI, ESCI (36)
ESCI (6)
Scopus (32)
TRDizin (6)
Diğer Yayınlar (1)

1. CSA-13 treatment in a murine model of Pseudomonas pneumonia-induced sepsis and its effects on renal injury, inflammation, and glycocalyx derangement.

Aksu U., Bozkurt-Guzel C., Erkose-Genc G., Tok O. E., Esrefoglu M., Oyardi Ö., et al.
The Journal of antibiotics , 2026 (SCI-Expanded, Scopus)

2. Epidemiology and antimicrobial resistance patterns of Aeromonas species in Europe, 2020-2024 (AEuROMONAS)

Boattini M., Bastos P., Gartzonika K., Christaki E., Mavromanolaki V. E., Maraki S., et al.
Diagnostic Microbiology and Infectious Disease , cilt.115, sa.4, 2026 (SCI-Expanded, Scopus)

3. Minor non-fermenting Gram-negative bacilli in Europe, 2020–2024 (MINOFEu)

Bianco G., Bastos P., Gartzonika K., Christaki E., Mavromanolaki V. E., Maraki S., et al.
International Journal of Antimicrobial Agents , cilt.67, sa.6, 2026 (SCI-Expanded, Scopus)

4. In Vitro Antimicrobial Activities of Carbapenem-beta Lactamase Inhibitor Combinations Against Carbapenem-resistant Gram-negative Pathogens Isolated from Türkiye

BİRTEKSÖZ TAN A. S., HACIOĞLU M., OYARDI Ö., Olcay F. N., Inan N.
Current Microbiology , cilt.83, sa.4, 2026 (SCI-Expanded, Scopus)

5. Synthesis and biological evaluation of some pyrimidine derivatives as multifunctional ligands for the treatment of Alzheimer's disease

Ozturk Ö., Oyardı Ö., Sagkan R. I., Dündar Y.
BIOORGANIC & MEDICINAL CHEMISTRY , cilt.132, 2026 (SCI-Expanded, Scopus)

6. Moraxella species isolated from blood cultures in Europe (MORAXEu): a multicentre study of epidemiology and antimicrobial susceptibility with complementary phylogenomic analysis of publicly available genomes

Tønjum T., da Silva Franklin-Duarte V., Berild J. C., Gartzonika K., Christaki E., Mavromanolaki V. E., et al.
European Journal of Clinical Microbiology and Infectious Diseases , 2026 (SCI-Expanded, Scopus)

7. Evaluation of the antimicrobial and antibiofilm activities of aztreonam-avibactam against the Burkholderia cepacia complex

OYARDI Ö., Celik D. D., TURAN T., AKSU M. B.
Folia Microbiologica , 2026 (SCI-Expanded, Scopus) Creative Commons License

8. In Vitro Antimicrobial Activity and In Vivo Effectiveness of the Cosmetic Products Developed for Oily Skin

ERDAL M. S., Aydilek N., GÜNGÖR S., DÖŞLER S., OYARDI Ö., Alici M., et al.
ISTANBUL JOURNAL OF PHARMACY , cilt.55, sa.2, ss.160-172, 2025 (ESCI, TRDizin) Sürdürülebilir Kalkınma

9. Evaluation of the in vivo assessment of Lycopodium complanatum L. ssp. chamaecyparissus (A.Braun ex Mutel) Doll extracts on TNF-α and IL-6

Özçelik B., Orhan I., Oyardi O., Demir Y. S., Turan T.
SOUTH AFRICAN JOURNAL OF BOTANY , cilt.182, ss.266-271, 2025 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

10. Assessment of the Anti-Acne Properties of Some Medicinal Plants and Development of an Herbal Anti-Acne Formulation

ŞENOL DENİZ F. S., OYARDI Ö., BOZKURT GÜZEL Ç., YALÇIN T. E., Yigitkan S., Kan Y., et al.
PHARMACEUTICS , cilt.17, sa.3, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Enhancing colistin efficacy with combination therapies for multidrug-resistant P. aeruginosa and A. baumannii isolates

Karaaslan E., OYARDI Ö., DÖŞLER S.
Future Microbiology , cilt.20, sa.7-9, ss.523-531, 2025 (SCI-Expanded, Scopus)

12. Quinazoline derivatives as novel bacterial sphingomyelinase enzyme inhibitors

Kuyrukçu Öztürk Ö., Oyardı Ö., Dündar Y.
Bioorganic Chemistry , cilt.154, 2025 (SCI-Expanded, Scopus)

13. Efficacy of aztreonam/avibactam against Stenotrophomonas maltophilia alone and in combination with tigecycline

OYARDI Ö., Altunboga G., OLCAY F. N., ERTURAN Z.
ISTANBUL JOURNAL OF PHARMACY , cilt.54, sa.3, ss.395-402, 2024 (ESCI, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

14. Efficacy of Zoliflodacin, a Spiropyrimidinetrione Antibiotic, Against Gram-Negative Pathogens

OYARDI Ö., Yilmaz F. N., DÖŞLER S.
CURRENT MICROBIOLOGY , cilt.81, sa.8, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Screening of antimicrobial, antibiofilm and cytotoxic activities of some medicinal plants from Balıkesir province, Türkiye: pointing to the potential effects of Allium paniculatum flower

Oyardı Ö., Hacıoğlu M., Özdemir Nath E., Erbay M. Ş., Kültür Ş., Bozkurt Güzel Ç.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.0, 2024 (ESCI, Scopus, TRDizin) Creative Commons License

16. Antimicrobial Activity of Ceragenins against Vancomycin-Susceptible and -Resistant Enterococcus spp.

HACIOĞLU M., YILMAZ F. N., OYARDI Ö., Guzel C. B., Inan N., Savage P. B., et al.
PHARMACEUTICALS , cilt.16, sa.12, 2023 (SCI-Expanded, Scopus)

17. Comparative evaluation of Medicinal Plant Extracts and Antimicrobial Magistrals

Muftah H., Özçelik B., Oyardı Ö., Deliorman Orhan D.
NEW MICROBIOLOGICA , cilt.46, sa.4, ss.361-366, 2023 (SCI-Expanded, Scopus) Creative Commons License

18. Phenotypic Investigation of Virulence Factors, Susceptibility to Ceragenins, and the Impact of Biofilm Formation on Drug Efficacy in Candida auris Isolates from Türkiye

OYARDI Ö., Demir E. S., Alkan B., Komec S., Genc G. E., AYGÜN G., et al.
Journal of Fungi , cilt.9, sa.10, 2023 (SCI-Expanded, Scopus) Creative Commons License

19. Antibacterial and Antibiofilm Activities of Ceragenins Alone and in Combination with Levofloxacin Against Multidrug Resistant Myroides spp. Clinical Isolates from Patients with Urinary Tract Infections

Oyardı Ö., Eltimur T., Demir E. S., Alkan B., Savage P. B., Akçalı A., et al.
Current Microbiology , cilt.80, sa.6, 2023 (SCI-Expanded, Scopus) Creative Commons License

20. Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria

Oyardı Ö., Hacıoğlu M., Yılmaz F. N., İnan N., Birteksöz Tan A. S.
Istanbul Journal of Pharmacy , cilt.53, sa.1, ss.45-50, 2023 (ESCI, TRDizin) Creative Commons License

21. Evaluation of the Antimicrobial Efficacy of Herbal Alternatives and Ozone in Root Canal Disinfection

Aktaş N., Öztaş Kırmızı N., Özçelik B., Oyardı Ö.
INDIAN JOURNAL OF APPLIED RESEARCH , cilt.13, sa.2, ss.70-73, 2023 (Hakemli Dergi) Creative Commons License

22. Screening of medicinal plant extracts as novel DNA gyrase inhibitors

Oyardı Ö., Özçelik B., Caliskan U. K., Şimay Demir Y. D., Ark M.
INDIAN JOURNAL OF TRADITIONAL KNOWLEDGE , cilt.22, sa.1, ss.211-219, 2023 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

23. Effects of Ceragenins and Antimicrobial Peptides on the A549 Cell Line and an In Vitro Co-Culture Model of A549 Cells and Pseudomonas aeruginosa

Oyardi Ö., Savage P. B., Guzel C. B.
Pathogens , cilt.11, sa.9, 2022 (SCI-Expanded, Scopus) Creative Commons License

24. Comparative Fungicidal Activities of N-Chlorotaurine and Conventional Antiseptics against Candida spp. Isolated from Vulvovaginal Candidiasis

Hacioglu M., Oyardı Ö., Yilmaz F. N., Nagl M.
JOURNAL OF FUNGI , cilt.8, sa.7, 2022 (SCI-Expanded, Scopus) Creative Commons License

25. In vitro activity of ceragenins against Burkholderia cepacia complex.

Demir E. S., Oyardi Ö., Savage P. B., Altay H. O., Bozkurt-Guzel C.
The Journal of antibiotics , cilt.75, ss.403-409, 2022 (SCI-Expanded, Scopus) Creative Commons License

26. Oregano essential oil inhibits Candida spp. biofilms

Hacıoğlu M., Oyardı Ö., Kirinti A.
ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES , cilt.76, sa.11-12, ss.443-450, 2021 (SCI-Expanded, Scopus) Creative Commons License

27. Gram Negatif Bakterilerin ve Steril Süpernatantlarının Candida albicans Biyofilmi Üzerine Etkilerinin Karşılaştırılması

Hacıoğlu M., Oyardı Ö.
Türk Mikrobiyoloji Cemiyeti Dergisi , cilt.51, sa.2, ss.163-171, 2021 (TRDizin) Creative Commons License

28. In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis

Oyardı Ö., Savage P. B., Erturan Z., Bozkurt-Guzel C.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , cilt.76, sa.2, ss.443-450, 2021 (SCI-Expanded, Scopus) Creative Commons License

29. Synergistic Activity of Ceragenins Against Carbapenem-Resistant Acinetobacter baumannii Strains in Both Checkerboard and Dynamic Time-Kill Assays

Bozkurt-Guzel C., Inci G., OYARDI Ö., Savage P. B.
CURRENT MICROBIOLOGY , cilt.77, sa.8, ss.1419-1428, 2020 (SCI-Expanded, Scopus) Creative Commons License

30. A comparative evaluation of Juniperus species with antimicrobial magistrals

Muftah H., Özçelik B., Oyardi Ö., Kutluk İ., Orhan N.
PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.33, sa.4, ss.1443-1449, 2020 (SCI-Expanded, Scopus) Creative Commons License

31. Antibiofilm activities of ceragenins and antimicrobial peptides against fungal-bacterial mono and multispecies biofilms

Hacıoğlu M., Oyardı Ö., Bozkurt-Guzel C., Savage P. B.
JOURNAL OF ANTIBIOTICS , cilt.73, sa.7, ss.455-462, 2020 (SCI-Expanded, Scopus) Creative Commons License

32. Biofilm modelling on the contact lenses and comparison of the in vitro activities of multipurpose lens solutions and antibiotics

Döşler S., Hacıoğlu M., Yılmaz F. N., Oyardi Ö.
PEERJ , cilt.8, 2020 (SCI-Expanded, Scopus) Creative Commons License

33. The Role of Amphotericin B Alone and in Combinationwith Different Antibiotics and Antifungals on BiofilmsProduced by Candida Species

Hacıoğlu M., Oyardı Ö., Özbek Çelik B.
FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.45, sa.2, ss.117-124, 2019 (Scopus, TRDizin) Creative Commons License

34. Risk factors associated with the frequency of antibodies to Francisella tularensis in two areas from Turkey

Ozdemir Z. O., Güneş T., Oyard Ö.
ISTANBUL JOURNAL OF PHARMACY , cilt.49, sa.3, ss.137-141, 2019 (ESCI) Creative Commons License Sürdürülebilir Kalkınma

35. Immunization against poly-N-acetylglucosamine reduces neutrophil activation and GVHD while sparing microbial diversity

Huelsduenker J., Thomas O. S., Haring E., Unger S., Nunez N. G., Tugues S., et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.116, sa.41, ss.20700-20706, 2019 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

36. Ceragenins exhibiting promising antimicrobial activity against various multidrug resistant Gram negative bacteria

OYARDI Ö., Savage P. B., AKÇALI A., ERTURAN Z., Bozkurt-Guzel C.
ISTANBUL JOURNAL OF PHARMACY , cilt.48, sa.3, ss.68-72, 2018 (ESCI) Creative Commons License

37. Comparative in vitro antimicrobial activities of CSA-142 and CSA-192, second-generation ceragenins, with CSA-13 against various microorganisms

Bozkurt Güzel Ç., Oyardı Ö., Savage P. B.
JOURNAL OF CHEMOTHERAPY , cilt.30, sa.6-8, ss.332-337, 2018 (SCI-Expanded, Scopus) Creative Commons License

38. Antimicrobial effect of the extracts from Hypericum perforatum against oral bacteria and biofilm formation

Süntar İ., Oyardı Ö., Akkol E., Özçelik B.
PHARMACEUTICAL BIOLOGY , cilt.54, sa.6, ss.1065-1070, 2016 (SCI-Expanded, Scopus) Creative Commons License

39. Synthesis and antimicrobial activities of new higher amino acid Schiff base derivatives of 6-aminopenicillanic acid and 7-aminocephalosporanic acid

Ozdemir (Nee Gungor) Ö., Gurkan P., Özçelik B., Oyardı Ö.
Journal of Molecular Structure , cilt.1106, ss.181-191, 2016 (SCI-Expanded, Scopus) Creative Commons License
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 23

1. ANTIMICROBIAL, ANTIBIOFILM, AND ANTI-VIRULENCE EFFECTS OF OMIGANAN–CLINDAMYCIN COMBINATION AGAINST CUTIBACTERIUM ACNES

Oyardı Ö., Erol İ., Turan T.
International Microbiological Societies Congress IUMS Biennial Congress 2026, Lisbon, Portekiz, 4 - 06 Kasım 2026, ss.1, (Özet Bildiri)

2. Determination of Antimicrobial Activity of Liquidambar orientalis Balsam Oil

OYARDI Ö.
The 12th Conference on Medicinal and Aromatic Plants of Southeast European Countries (CMAPSEEC-2024), 17 - 19 Ekim 2024, (Özet Bildiri)

3. Effects of Ceragenins on C. auris Esterase Activity

OYARDI Ö.
5th World conference on Virology, Microbiology and infectious diseases, İngiltere, 29 - 30 Temmuz 2024, (Özet Bildiri)

4. Aztreonam/avibactam effectiveness for aztreonam resistant Stenotrophomonas maltophilia strains

OYARDI Ö.
34th European Congress of Clinical Microbiology and Infectious Diseases, Barselona, İspanya, 27 - 30 Nisan 2024, (Özet Bildiri)

5. Searching the potential application of CSA-131 as a Coating Material for Implant Surfaces

Oyardı Ö.
Antibiotics 2024, London, İngiltere, 14 - 15 Mart 2024, (Özet Bildiri)

6. Development of a murine model of Neisseria gonorrhoeae conjunctivitis and evaluation of immunity targeting the conserved surface polysaccharide, poly-N-acetyl glucosamine (PNAG)

Zaidi T., Cywes Bentley C., Vinacur M., Oyardı Ö., Pier G.
23rd International Pathogenic Neisseria Conference, Massachusetts, Amerika Birleşik Devletleri, 8 - 10 Kasım 2023, ss.1-2, (Özet Bildiri) Creative Commons License

7. Evaluation of the effects of CSA-131 - hydrogel coated silicone implants on the development of biofilm and capsular contracture

Bozkurt Güzel Ç., Oyardı Ö., Ertekin C., Ozturk M. B., Olgun Z. C., Aksan ., et al.
FEMS 2023, Hamburg, Almanya, 9 - 13 Temmuz 2023, ss.476, (Özet Bildiri) Creative Commons License

8. Investigation of the protective effect of monoclonal antibodies against poly-N-acetyl glucosamine (PNAG), a superficial polysaccharide, as an alternative to antibiotic- containing eye drops for the prevention of neonatal eye infections caused by Neisseria gonorrhoeae.

BOZKURT GÜZEL Ç., OYARDI Ö., Zaidi T., Pier G.
Louis Pasteur Congress, Polonya, 29 Kasım 2022, (Özet Bildiri) Creative Commons License

9. Efficacy of N-Chlorotaurine against Candida spp. isolated from vulvovaginal candidiasis.

HACIOĞLU M., OYARDI Ö., Nagl M.
Federation of European Microbiological Societies (FEMS) Online Conference on Microbiology 2020, 28 Ekim 2022, (Özet Bildiri) Creative Commons License

10. Thyme Essential oil inhibits biofilms of Candida spp.

HACIOĞLU M., OYARDI Ö., Kırıntı A.
Federation of European Microbiological Societies (FEMS) Online Conference on Microbiology 2020, 28 Ekim 2022, (Özet Bildiri) Creative Commons License

11. Tıbbi Bitkilerimizden Hareketle Anti-Akne Etkili Nanoemülsiyon Prototip Ürün Formülasyonu Geliştirilmesi

Şenol Deniz F. S., Oyardı Ö., Bozkurt Güzel Ç., Ülger N., Kan Y., Yalçın T. E., et al.
24. Bitkisel İlaç Hammaddeleri Toplantısı (BİHAT 2022), Ankara, Türkiye, 23 - 26 Haziran 2022, ss.150-151, (Özet Bildiri)

12. The efficacy of ceragenins against first Candida auris strains isolated in Turkey

Alkan B., OYARDI Ö., KÖMEÇ S., ERKÖSE GENÇ G., ERTURAN Z., SAVAGE P., et al.
32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), 23 Nisan 2022, (Özet Bildiri) Creative Commons License

13. Activities of cationic steroid antibiotics against Myroides spp., from Turkish hospitals

Demir E. S., ELTİMUR KARATOPRAK T., OYARDI Ö., BOZKURT GÜZEL Ç., AKÇALI A., SAVAGE P.
32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), 23 Nisan 2022, (Özet Bildiri) Creative Commons License

14. Vaccination Against Poly-N-Acetylglucosamine Decreases Neutrophil Activation and Gvhd While Maintaining Microbial Diversity

Haring E., Hulsdunker J., Thomas O., Unger S., Nunez N., Tugues S., et al.
61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 7 - 10 Aralık 2019, cilt.134, (Özet Bildiri) Sürdürülebilir Kalkınma

15. Enterecoccus Faecalis Biyofilmi Üzerine Çeşitli Ajanların Antimikrobiyal Etkinliğinin Lazer Taramalı Konfokal Mikroskop ile Değerlendirilmesi

Aktaş N., Öztaş N., Özçelik B., Oyardı Ö.
25 th International Dental Congress, İstanbul, Türkiye, 4 - 07 Eylül 2019, (Özet Bildiri)

16. Ceragenins Exhibiting Significant Antimicrobial Potential Against Various Colistin-resistant Gram-Negative Bacteria.

HACIOĞLU M., OYARDI Ö., BOZKURT GÜZEL Ç., SAVAGE P.
The 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2018, 21 Nisan 2018, (Özet Bildiri) Creative Commons License

17. Comparative in vitro antimicrobial activities of the second generation ceragenins CSA-142 and CSA-192, with CSA-13, against carbapenem-resistant Acinetobacter baumannii

BOZKURT GÜZEL Ç., OYARDI Ö.
Acinetobacter 2017, Sevilla, İspanya, 20 - 22 Eylül 2017, (Özet Bildiri)

18. Evaluation of success of antibiotic therapy with some blood biomarkers in community-acquired pneumonia

OYARDI Ö., NEBİOĞLU M. D.
the clinical pharmacy congress, Londrina, Brezilya, 12 - 13 Mayıs 2017, (Özet Bildiri)

19. Comparative in-vitro antimicrobial activities of CSA-142 and CSA-192, the second generation of ceragenins, with CSA-13

BOZKURT GÜZEL Ç., OYARDI Ö.
The ECCMID 2017, viyana, Avusturya, 22 - 25 Nisan 2017, (Özet Bildiri) Creative Commons License

20. Evaluation of Antimicrobial Efficacy of Ozone and Herbal Alternatives in Root Canal Disinfection An In Vitro Study

Aktaş N., Öztaş N., Özçelik B., Oyardı Ö.
1.Uluslararsı ORAD Kongresi, Ankara, Türkiye, 18 - 20 Kasım 2016, (Tam Metin Bildiri)

21. Evaluation of Antimicroal Efficieny of Ozone and Herbal Alternatives in root canal disinfection An In vitro Study

Aktaş N., Öztaş N., Özçelik B., Oyardı Ö.
1.Uluslararası ORAD Kongresi, Ankara, Türkiye, 18 - 20 Kasım 2016, (Tam Metin Bildiri)

22. Antimicrobial effect of the extract and fractions from Hypericum perforatum L. against oral bacteria and biofilm formation

Süntar İ., Oyardı Ö., Akkol E., Özçelik B.
III International Conference on Antimicrobial Reserch-ICAR2014, Madrid, İspanya, 1 - 03 Ekim 2014, ss.1-2, (Özet Bildiri)

23. Antimicrobial Effect of the extract and fractions from Hypericum perforatum L. against oral bacteria and biofilm formation.

Süntar İ., Oyardı Ö., Akkol E., Özçelik B.
International Multidisciplinary Symposium on Drug Research and Development, Antalya, Türkiye, 28 - 30 Kasım 2013, (Özet Bildiri)
Metrikler

Yayın

64

Yayın (WoS)

37

Yayın (Scopus)

32

Atıf (WoS)

150

H-İndeks (WoS)

9

Atıf (Scopus)

156

H-İndeks (Scopus)

8

Atıf (TrDizin)

2

H-İndeks (TrDizin)

1

Atıf (Sobiad)

2

H-İndeks (Sobiad)

1

Proje

17

Tez Danışmanlığı

1

Açık Erişim

19
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER
SDG 16: AMAÇ 16: BARIŞ VE ADALET